Member Info for EmeraldCarrots

Angles assay. Angle say they launched it at the World CB & CDx.

https://x.com/parsortix/status/1833057895723806872?s=67&t=BBb2UcjLDTXOFIzJM-vM6A

Looks like they already sold it to Eisai Inc. of Japan back in January!!!!

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

I wonder if they had an agreement not to sell it to any other Company for 6 months? They do own the assays once done as the RNS's state. It seems odd they did not launch it sooner?

As the circulating tumour cells originate from a tumour (and only last a few hours) catching them with Angles Parsortix machine and testing the HER2 proteins must reveal the HER2 status of the cancer which is all important (HER2 positive, negative or low).

Massive money earner in due course. Possibly tens if not hundreds of millions of £.

All IMHO.

I think you bought back several weeks ago and now you have sold again? Why not wait for the official news rather than the chat of BB's which is aften complete rubbish. The lack on RNS's of late (last 3 months or so) does not necessarily mean the updates won't be ok. They do sell the Parsortix machine (about $60,000 each) and the consumables that it needs do they not? It just means no MAJOR new clients like Eisai and Astrazeneca have signed up...... yet. They won't be doing an RNS every time they sell some of their services anyway. As far as I am concerned the longer we have no Eisai type RNS's the closer we are to getting one. Should be close.........

All IMHO.

I mean, just because Mr Newland has said he expects to sign up a couple more "household names" like Astrazeneca by the end of the year. Maybe he is in fact talking to Andrex so they can have enough loo paper to hand when the interims are published? LOL!

Is expecting a poor update from Angle later this month. The placing in June was at 15p a share so a fairly big disaster is priced in already. We will see............ Last time it was at this level did it not spike to 31p on the Eisai news?

They may have officially launched it last week buyt clearly it has been available since Jan!??

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

Maybe it will warrant an RNS to say what system they will be using for the DNA analysis. Most likely Illumina I think.

https://angleplc.com/laboratory-services/

Currently offering the following standardised analyses:

Enumeration of epithelial, mesenchymal and epithelial-to-mesenchymal transitioning (EMT) CTCs and CTC clusters

DNA Damage Response (DDR) proteins

PD-L1 protein expression analysis

HER2

****Additional assays currently in development:****

CTC DNA / ctDNA combined profiling

You will see he/she does not contribute anything, just criticises all the time. Never posts anything of substance.

All IMHO.

Posts about Angle Plc. I'm sure you know this "Proline" post is nothing to do with me. It is positive in itself that about 180 Companies will be showcasing at this massive conference and it is about "liquid biopsies" which if course is exactly what Angle are about. I really did not realise how much it has taken off. Shame the sp here has not too, but with the likes of you doing your level best to stop people posting on here I'm not entirely surprised. I mean, have you ever posted anything positive?? If you have I certainly don't remember. All you do is criticise other peoples posts from what I have seen.

https://www.esmo.org/meeting-calendar/esmo-congress-2024

What Angle have been up to. Clearly the market expects some sort of disaster considering the placing in June this year (only 3 months ago) was @ 15p a share. Now the sp is only 12p!!!!!!

Fingers crossed.

Post. It points out that circulating tumour cells are in the blood supply for a few hours, come from a tumour, and so should be a good upto date source of information about the cancer.

Don't forget the sp was up last Friday and the general market was very bad.............

The recent low was bid 2.2p I think. When the sp moved up from that I think the overhang had gone.

I hope!

FDA application for the CYP2C19-ID Kit to join the other one.

Sales to more of the 100 or so Trusts in the NHS

Sales to other Countries.

New distributors in other Countries.

More Director share buys.

- Not that hard for GDR to come up with regular news flow I think.

Blood? From the WWW:-

"Circulating tumour cells, or CTCs, are cells that are shed from tumours into the bloodstream. After release from tumours, most CTCs die in the circulation (in ~1–2.5 h) owing to mechanical forces or immune system attack.".

====================================

So, these CTC's are "fresh" from a tumour somewhere. It seems to me being able to catch 99% live and intact samples of these CTC's using Angle's Parsortix machine and analyse them is extremely highly likely to reveal the current state of the cancer. Be it HER2 positive, HER2 negative, HER2 low, PD-L1 level etc... Companies doing cancer research should be falling over each other in the rush to employ Angle to test these CTC's.

I have a feeling they will be in due course.

All IMHO.

Look (European Society for Medical Oncology).

https://www.esmo.org/meeting-calendar/esmo-congress-2024

https://www.esmo.org/meeting-calendar/esmo-congress-2024/industry-participation

ANGLE, AstraZeneca, Eisai, Illumina all there plus about 180 others. Massive event.

To stem from email correspondance with Genedrive. If they are real you can post the actual emails, but you don't. Not to be trusted.

Which let's be honest is unusual of late! More next week I hope!

If the people who do the buying of kit at Hospitals in the UK don't realise that both the The Genedrive® MT-RNR1 ID Kit (hearing one) and the CYP2C19-ID Kit (stroke one) are machines that will save hours if not days of time and money waiting for a lab result then I don't believe it. These machines are going to sell like hot cakes once momentum builds.

All IMHO.

Duggs999

"The fact that you have a time critical result for stroke patient treatment a couple of days earlier than the lab test technically should save at least 2 days of each patient taking up a hospital bed. 1. at circa £350 per day NHS cost, and 2. the ethical benefit of freeing up those beds for patients stuck in ambulances queuing outside the UK hospital!".

======================================

I am minded to buy something that will clearly save me money over time.

Most people can understand that and make the correct decision.

Unfortunately there are some people who simply cannot compute this.

Then they lose but are ignorant about the loss.

Https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

I also expect the RNS detailing the FDA application for the other CYP2C19-ID Kit any day. It is totally obvious they will seek FDA approval for this machine too, unless thay are completely stupid? LOL! No, please don't say anything.......

All IMHO.

Up? Post some backup or shut up. This whole site is absolutely full of lies.